Evaluation of miR-122 levels in chronic HBV and liver cirrhosis patients
Archives of Medical Laboratory Sciences,
Vol. 2 No. 3 (2016),
23 Azar 2016
https://doi.org/10.22037/amls.v2i3.16757
Abstract
Background: MicroRNA is a type of small RNA of about 22 nucleotide length. Most popular miRNAs are found in the liver and are extensively important in determining the biological and clinical functions. MicroRNA, in host cells, may impact the replication of viruses either positively or negatively. In this study the miR-122 expression was examined and compared in three groups, two sample groups of patients with chronic hepatitis and hepatitis B virus-associated cirrhosis, and a healthy control group.
Materials and Methods: In this study, 108 samples of whole blood were taken from each participant. Then the miRNA expression evaluation was conducted through relative real time PCR.
Results: The results indicated that miR-122 expression was elevated in patients with chronic hepatitis B and HBV related cirrhosis about 1.8 times (P<0.05) more than control group which is statistically significant.
Conclusion: According to the results of this study, measuring the miR-122 expression levels may be used as a biomarker and an indicator of the disease progression of chronic hepatitis B to HBV related cirrhosis to HCC, but needs more investigations and more samples.
- microRNA
- chronic hepatitis B
- liver cirrhosis
- miR-122
How to Cite
References
Robinson SW: Hepatitis B virus and hepatitis D virus. In: Mandell GL, Bennet JE, and Dolin R, (eds.), Principle and practice of Infectious Disease. New York: Churchill Livingstone, pp. 1406-1439, 2000.
Wooddell CI, Rozema DB, Hossbach M, John M, Hamilton HL, Chu Q, at al. Hepatocyte-targeted RNAi therapeutics for the treatment of chronic hepatitis B virus infection. Mol Ther 2013; 21: 973-985.
Thomas F Baumert, Robert Thimme, Fritz von Weizsacker . Pathogenesis of hepatitis B virus infection. World J Gastroenterol 2007 January 7; 13(1): 82-90.
Xia J, Tatsuo K, Shuang Wu, Masato N, Tatsuo M, Shingo N, at al. Regulation of microRNA by hepatitis B virus infection and their possible association with control of innate immunity. World J Gastroenterol 2014 June 21; 20(23): 7197-7206.
Jian Zh, Lei Yu, Xue G, Jie Hu, Jiping W, Zhi D, at al. Plasma MicroRNA Panel to Diagnose Hepatitis B Virus–Related Hepatocellular Carcinoma. Journal of Clinical Oncology, Volume 29, Number 36, December 2011, 4781-4788.
Coulouarn C, Factor VM, Andersen JB, Durkin ME, Thorgeirsson SS. (2009). Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties. Oncogene; 28(40):3526-36.
Muriel G, Emmanuel J, Arnold M, Stanislas L, Alexandra H. miR-122, a paradigm for the role of microRNAs in the liver. Journal of Hepatology 48 (2008) 648–656.
Xiaoyong Zh, Jinlin H, Mengji Lu. Regulation of hepatitis B virus replication by epigenetic mechanisms and microRNAs. Frontiersin Genetics, Epigenomics and Epigenetics. October 2013, Volume4, Article 202.
L Qiu, H Fan, W Jin, B Zhao, Y Wang, Y Ju, L Chen. miR-122-induced down-regulation of HO-1 negatively affects miR-122-mediated suppression of HBV. Biochemical and Biophysical Research Communications 398 (2010) 771–777.
Jian Zh, Lei Yu, Xue G, Jie Hu, Jiping W, Zhi D, at al. Plasma MicroRNA Panel to Diagnose Hepatitis B Virus–Related Hepatocellular Carcinoma. Journal of Clinical Oncology, Volume 29, Number 36, December 2011, 4781-4788.
- Abstract Viewed: 472 times
- PDF Downloaded: 376 times